|Articles|November 6, 2017

Mapping C. difficile Exposures and Infections in the Hospital

Can we track Clostridium difficile infections to see how patient movements result in exposures?

Mitigating Clostridium difficile (C. difficile) infections are a challenging aspect of health care infection control. Prevention efforts cover an array of services and include strategies ranging from environmental services to laboratory guidance to antimicrobial stewardship, and more. New studies continue to highlight emerging preventive measures, such as the importance of patient involvement in hand hygiene efforts; however, the truth is that there are many pieces to the prevention of C. difficile infections and we continue to struggle to get a handle on this nuisance.

Hand hygiene, pathogen exposure, isolation technique, exposure to antibiotics, cleaning and disinfecting practices, and many other factors impact the spread of C. difficile throughout a health care facility. It would be valuable to learn exactly how this spore-forming organism moves through a health care facility. For example, if a patient with a C. difficile infection is in the emergency department and a non-infected patient comes in a few hours later, are they at risk?

Investigators on a new study sought to answer these questions through the use of spatial and temporal mapping of C. difficile to identify nosocomial transmission. During an evaluation of a large university hospital during one month in 2013 and 2015, investigators considered the space (emergency department, operating room, cardiology, ultrasound, etc) that was contaminated for 24 hours following a patient with C. difficile being in the space. Patients that were exposed (ie, passed through that space while it was considered contaminated) were followed for 60 days. If a patient developed C. difficile within 24 hours of their exposure, it was not considered related to the exposure (as the incubation period would be too short). The investigators used the hospital’s electronic medical records system and excluded patients who already had a C. difficile infection within the past year.

After reviewing 86,648 adult hospitalizations and a whopping 434,745 patient location changes during the study periods, the investigators found 1152 laboratory-confirmed cases of C. difficile. Those patients who were positive had moved through a mean of 4.2 hospital spaces (which also means they likely contaminated the spaces they moved through).

The investigators found that both exposure and risk of developing C. difficile infection following exposure tended to vary but being exposed in the emergency department computed tomography scanner (CT) area was significantly associated with developing C. difficile. Although not statistically significant, the incidence of C. difficile among exposed patients was also higher in nuclear medicine, and bone marrow transplant (BMT) and magnetic resonance imaging (MRI) suites.

All told, this means that those patients who visit a hospital emergency room CT after a patient with C. difficile has been in the space (within the last 24 hours), are at an increased risk of becoming infected themselves. This study is fascinating in that it addresses the role of environmental contamination and frequent patient movement within health care. Although I think the exposure window of 24 hours after the space was “contaminated” may be a bit short, given how tough disinfecting is and the inconsistencies in cleaning, this research gives new insight into higher risk areas for C. difficile transmission.


Related to this article

Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.